ArticleBioengineering (Basel, Switzerland)2022

Isolation of NELL 1 Aptamers for Rhabdomyosarcoma Targeting.

Chengchen Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.